Kamble Ravindra Bhimrao, N Jayakumar Peruvumba, Shivashankar Ravishankar
Head of Department, Department of Radiology, Bangalore, Karnataka, India .
Head of Department, Department of Radiology, Muscat, Oman .
J Clin Diagn Res. 2015 May;9(5):TC01-5. doi: 10.7860/JCDR/2015/11587.5880. Epub 2015 May 1.
To study perfusion characteristics of intracranial tuberculomas and analyze changes with anti tubercular treatment.
Nineteen patients of histologically proven intracranial tuberculomas were included in the study of which 9 were not on antitubercular treatment and ten were on antitubercular treatment (6 patients on treatment for less than 2 months and 4 were more than 6 months). All patients underwent CT perfusion (CTP) and CTP parameters like rCBV and rCBF were obtained from entire lesion, center and capsule of lesions and compared.
CTP parameters like rCBF and rCBV were significantly low in all the three ROIs in the group not on treatment compared to that of on treatment ; rCBF and rCBV of entire lesion (p=0.018 and p=0.005 respectively), capsule (p=0.045 and p=0.010 respectively) and center of the lesion (p=0.020 and p=0.009) respectively). Tuberculomas on antitubercular treatment of more than six months showed reduced rCBF and rCBV in entire lesion (p=0.01 & p=0.01 respectively), capsule (p=0.04 & p=0.03 respectively) and center (p=0.08 & p=0.05 respectively) compared to those on treatment for less than two months. Similarly tuberculomas on treatment for six months did not show significant difference in rCBF and rCBV compared to tuberculomas who were not on treatment. Tuberculomas on treatment for less than two months showed statistically increased rCBF and rCBV in entire lesion (p=0.01 & p=0.04 respectively), capsule (p=0.03 & p=0.01 respectively) and center (p= 0.03 &=0.01) compared to those not on treatment.
Intracranial tuberculomas not on treatment and those on treatment for around six months show low perfusion and tuberculomas on treatment for less than two months show high perfusion. These findings suggest that serial perfusion profiles of tuberculomas on treatment could possibly be seen as surrogate markers of response to treatment.
研究颅内结核瘤的灌注特征,并分析抗结核治疗后的变化。
本研究纳入19例经组织学证实的颅内结核瘤患者,其中9例未接受抗结核治疗,10例接受抗结核治疗(6例治疗时间少于2个月,4例超过6个月)。所有患者均接受CT灌注(CTP)检查,并从病变整体、病变中心及包膜获取CTP参数,如相对脑血容量(rCBV)和相对脑血流量(rCBF),并进行比较。
与接受治疗的组相比,未接受治疗组的所有三个感兴趣区(ROI)的CTP参数,如rCBF和rCBV均显著降低;病变整体的rCBF和rCBV(分别为p = 0.018和p = 0.005)、包膜(分别为p = 0.045和p = 0.010)以及病变中心(分别为p = 0.020和p = 0.009)。与治疗时间少于2个月的结核瘤相比,接受抗结核治疗超过6个月的结核瘤在病变整体(分别为p = 0.01和p = 0.01)、包膜(分别为p = 0.04和p = 0.03)以及中心(分别为p = 0.08和p = 0.05)的rCBF和rCBV均降低。同样,治疗6个月的结核瘤与未接受治疗的结核瘤相比,rCBF和rCBV无显著差异。与未接受治疗的结核瘤相比,治疗时间少于2个月的结核瘤在病变整体(分别为p = 0.01和p = 0.04)、包膜(分别为p = 0.03和p = 0.01)以及中心(分别为p = 0.03和p = 0.01)的rCBF和rCBV在统计学上有所增加。
未接受治疗的颅内结核瘤以及治疗约6个月的结核瘤显示灌注较低,而治疗时间少于2个月的结核瘤显示灌注较高。这些发现表明,治疗中结核瘤的系列灌注情况可能被视为治疗反应的替代标志物。